Estrogen upregulates the prolactin receptors (PRLR) on pituitary tumor cells through ERα, so the binding of prolactin to the PRLR induces phosphorylation of ERα, leading to a cascade of molecular reactions causing DA resistance and promoting pituitary tumor enlargement and invasiveness [21]. The gene discussed is ESR1; the disease is pituitary tumor.